ADV NURS SCI 润色咨询

ADVANCES IN NURSING SCIENCE

出版年份:1978 年文章数:1151 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:11.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=847491, encodeId=3d7284e491fb, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:文章质量比较一般,还是可以一投的,中了两篇审稿都很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Fri Sep 28 17:38:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098573, encodeId=cde210985e32e, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098574, encodeId=921810985e443, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2018-09-28 ms1947553951244386

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:文章质量比较一般,还是可以一投的,中了两篇审稿都很快

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=847491, encodeId=3d7284e491fb, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:文章质量比较一般,还是可以一投的,中了两篇审稿都很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Fri Sep 28 17:38:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098573, encodeId=cde210985e32e, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098574, encodeId=921810985e443, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    是否需要在讨论中说明文章局限性?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=847491, encodeId=3d7284e491fb, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:文章质量比较一般,还是可以一投的,中了两篇审稿都很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Fri Sep 28 17:38:42 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098573, encodeId=cde210985e32e, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098574, encodeId=921810985e443, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 rayms

    讨论中局限性怎么撰写?

    1

    展开1条回复
共6条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分